Avista Healthcare Partners, a private equity firm focused exclusively on healthcare, announced its acquisition of EBI, the bone healing division of Highridge Medical.
The acquisition marks the 50th platform healthcare investment for Avista and its founding members.
Headquartered in Parsippany, New Jersey, EBI specializes in electrobiology solutions with a portfolio of implantable and non-invasive bone growth stimulation devices to support bone regeneration and healing outcomes.
Kevin Kenny, an Avista strategic executive, joined EBI as CEO at closing. Kenny brings experience in the medical device sector, having most recently served as president of the global spine segment at Orthofix Medical, where he led the global spinal implants, motion preservation, bone growth therapies, and biologics businesses.
“I am thrilled to be a part of EBI’s next chapter as a standalone company. I am confident in EBI’s ability to advance its leadership in bone healing technologies, driven by strategic initiatives and a relentless commitment to excellence. Our focus is clear as we position EBI as the most innovative leader in bone healing science — delivering solutions that improve patient outcomes,” said Kevin Kenny.
![Chamfr Velocity[84][1][41][55]](https://img.medicaldesigndevelopment.com/files/base/indm/multi/image/2023/06/Chamfr_Velocity_84__1__41__55_.64877739c2c17.png?auto=format%2Ccompress&fit=crop&h=167&q=70&rect=18%2C0%2C1791%2C1008&w=250)
